As of 3:59pm ET
| -0.34 / -1.18%|
The 8 analysts offering 12-month price forecasts for Insmed Inc have a median target of 38.00, with a high estimate of 54.00 and a low estimate of 17.00. The median estimate represents a +33.33% increase from the last price of 28.50.
The current consensus among 8 polled investment analysts is to Buy stock in Insmed Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.